EP 0859779 A1 19980826 - INTERLEUKIN CONVERTING ENZYME AND APOPTOSIS
Title (en)
INTERLEUKIN CONVERTING ENZYME AND APOPTOSIS
Title (de)
INTERLEUKIN-KONVERTIERENDES ENZYM UND APOPTOSIS
Title (fr)
ENZYME DE CONVERSION D'INTERLEUKINE ET APOPTOSE
Publication
Application
Priority
- US 9613967 W 19960829
- US 308295 P 19950831
Abstract (en)
[origin: WO9708174A1] The present invention is to the novel compounds of Formula (I), their pharmaceutical compositions, and to the novel inhibition of ICE and ICE-like proteins for use in the treatment of apoptosis, and disease states caused by excessive or inappropriate cell death.
IPC 1-7
IPC 8 full level
A61K 31/00 (2006.01); A61K 31/545 (2006.01); A61K 31/546 (2006.01); A61P 1/00 (2006.01); A61P 1/16 (2006.01); A61P 9/00 (2006.01); A61P 9/10 (2006.01); A61P 19/00 (2006.01); A61P 19/02 (2006.01); A61P 19/08 (2006.01); A61P 25/28 (2006.01); A61P 31/00 (2006.01); A61P 31/12 (2006.01); A61P 43/00 (2006.01); C07D 501/00 (2006.01)
CPC (source: EP)
A61P 1/00 (2017.12); A61P 1/16 (2017.12); A61P 9/00 (2017.12); A61P 9/10 (2017.12); A61P 19/00 (2017.12); A61P 19/02 (2017.12); A61P 19/08 (2017.12); A61P 25/28 (2017.12); A61P 31/00 (2017.12); A61P 31/12 (2017.12); A61P 43/00 (2017.12); C07D 501/00 (2013.01)
Designated contracting state (EPC)
BE CH DE ES FR GB IT LI NL
DOCDB simple family (publication)
WO 9708174 A1 19970306; EP 0859779 A1 19980826; EP 0859779 A4 20000412; JP H11511463 A 19991005
DOCDB simple family (application)
US 9613967 W 19960829; EP 96932941 A 19960829; JP 51059097 A 19960829